KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $140000.0.

  • Nektar Therapeutics' Other Operating Expenses fell 9687.57% to $140000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.3 million, marking a year-over-year decrease of 16692.96%. This contributed to the annual value of $6.0 million for FY2024, which is 9619.36% down from last year.
  • Per Nektar Therapeutics' latest filing, its Other Operating Expenses stood at $140000.0 for Q3 2025, which was down 9687.57% from $447000.0 recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Other Operating Expenses peaked at $103.2 million during Q1 2023, and registered a low of -$31.1 million during Q4 2024.
  • In the last 5 years, Nektar Therapeutics' Other Operating Expenses had a median value of $6.2 million in 2021 and averaged $12.0 million.
  • As far as peak fluctuations go, Nektar Therapeutics' Other Operating Expenses soared by 184084.67% in 2023, and later plummeted by 47649.13% in 2024.
  • Nektar Therapeutics' Other Operating Expenses (Quarter) stood at $6.2 million in 2021, then surged by 144.33% to $15.1 million in 2022, then crashed by 45.23% to $8.2 million in 2023, then tumbled by 476.49% to -$31.1 million in 2024, then surged by 100.45% to $140000.0 in 2025.
  • Its last three reported values are $140000.0 in Q3 2025, $447000.0 for Q2 2025, and $169000.0 during Q1 2025.